Form 4: ANI Pharmaceuticals SVP Marken Sells Shares

James G. Marken, SVP of Operations & Product Development at ANI Pharmaceuticals, sold 24,338 shares of common stock at an average price of $66.37 on March 7, 2024.

Summary

• On March 7, 2024, James G. Marken, SVP of Operations & Product Development at ANI Pharmaceuticals, sold 24,338 shares of common stock.
• The shares were sold at a weighted average price of $66.37, with individual sales prices ranging from $66.00 to $66.75.
• Additionally, 2,034 shares were withheld for tax purposes in connection with the vesting of 6,644 shares of restricted stock.
• Following these transactions, Marken directly owns 122,458 shares of ANI Pharmaceuticals.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard SEC filing reporting an insider stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This is a routine disclosure of insider trading activity. It's important to monitor such filings to understand management's perspective on the company's stock and future prospects. However, one individual's transactions may not be indicative of broader trends.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, depending on the market's interpretation of the transaction.

Key Dates